242 related articles for article (PubMed ID: 37380530)
1. Ferroptosis of immune cells in the tumor microenvironment.
Kim R; Taylor D; Vonderheide RH; Gabrilovich DI
Trends Pharmacol Sci; 2023 Aug; 44(8):542-552. PubMed ID: 37380530
[TBL] [Abstract][Full Text] [Related]
2. Ferroptosis-mediated immune responses in cancer.
Qi D; Peng M
Front Immunol; 2023; 14():1188365. PubMed ID: 37325669
[TBL] [Abstract][Full Text] [Related]
3. Ferroptosis and tumor immunity: In perspective of the major cell components in the tumor microenvironment.
Zhu W; Liu X; Yang L; He Q; Huang D; Tan X
Eur J Pharmacol; 2023 Dec; 961():176124. PubMed ID: 37925133
[TBL] [Abstract][Full Text] [Related]
4. The putative role of ferroptosis in gastric cancer: a review.
Wang L; Wang H
Eur J Cancer Prev; 2023 Nov; 32(6):575-583. PubMed ID: 37318883
[TBL] [Abstract][Full Text] [Related]
5. Modulating ferroptosis sensitivity: environmental and cellular targets within the tumor microenvironment.
Hua Y; Yang S; Zhang Y; Li J; Wang M; Yeerkenbieke P; Liao Q; Liu Q
J Exp Clin Cancer Res; 2024 Jan; 43(1):19. PubMed ID: 38217037
[TBL] [Abstract][Full Text] [Related]
6. Ferroptosis Nanomedicine: Clinical Challenges and Opportunities for Modulating Tumor Metabolic and Immunological Landscape.
Yang H; Yao X; Liu Y; Shen X; Li M; Luo Z
ACS Nano; 2023 Aug; 17(16):15328-15353. PubMed ID: 37573530
[TBL] [Abstract][Full Text] [Related]
7. The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions.
Lei G; Zhuang L; Gan B
Cancer Cell; 2024 Apr; 42(4):513-534. PubMed ID: 38593779
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis at the crossroads of tumor-host interactions, metastasis, and therapy response.
Yao Y; Shi Y; Gao Z; Sun Y; Yao F; Ma L
Am J Physiol Cell Physiol; 2022 Jul; 323(1):C95-C103. PubMed ID: 35613358
[TBL] [Abstract][Full Text] [Related]
9. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
[TBL] [Abstract][Full Text] [Related]
10. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.
Tong X; Tang R; Xiao M; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
J Hematol Oncol; 2022 Dec; 15(1):174. PubMed ID: 36482419
[TBL] [Abstract][Full Text] [Related]
11. The role of lipid metabolic reprogramming in tumor microenvironment.
Yang K; Wang X; Song C; He Z; Wang R; Xu Y; Jiang G; Wan Y; Mei J; Mao W
Theranostics; 2023; 13(6):1774-1808. PubMed ID: 37064872
[TBL] [Abstract][Full Text] [Related]
12. Emerging mechanisms and targeted therapy of ferroptosis in cancer.
Wang H; Cheng Y; Mao C; Liu S; Xiao D; Huang J; Tao Y
Mol Ther; 2021 Jul; 29(7):2185-2208. PubMed ID: 33794363
[TBL] [Abstract][Full Text] [Related]
13. [Research progress on ferroptosis in tumor immunity].
Ji J; Liu S; Liao X; Wang D; Zhu H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Apr; 40(4):362-366. PubMed ID: 38710519
[TBL] [Abstract][Full Text] [Related]
14. Ferroptosis-mediated Crosstalk in the Tumor Microenvironment Implicated in Cancer Progression and Therapy.
Liu Y; Duan C; Dai R; Zeng Y
Front Cell Dev Biol; 2021; 9():739392. PubMed ID: 34796174
[TBL] [Abstract][Full Text] [Related]
15. Ferroptosis-Driven Nanotherapeutics to Reverse Drug Resistance in Tumor Microenvironment.
Zhu L; Meng D; Wang X; Chen X
ACS Appl Bio Mater; 2022 Jun; 5(6):2481-2506. PubMed ID: 35614872
[TBL] [Abstract][Full Text] [Related]
16. Iron Metabolism in the Tumor Microenvironment-Implications for Anti-Cancer Immune Response.
Sacco A; Battaglia AM; Botta C; Aversa I; Mancuso S; Costanzo F; Biamonte F
Cells; 2021 Feb; 10(2):. PubMed ID: 33540645
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of ferroptosis in cancer: a matter of context?
Catanzaro E; Demuynck R; Naessens F; Galluzzi L; Krysko DV
Trends Cancer; 2024 May; 10(5):407-416. PubMed ID: 38368244
[TBL] [Abstract][Full Text] [Related]
18. Ferroptosis: Promising approach for cancer and cancer immunotherapy.
Zheng S; Guan XY
Cancer Lett; 2023 May; 561():216152. PubMed ID: 37023938
[TBL] [Abstract][Full Text] [Related]
19. Ferroptosis induction via targeting metabolic alterations in head and neck cancer.
Lee J; Roh JL
Crit Rev Oncol Hematol; 2023 Jan; 181():103887. PubMed ID: 36442748
[TBL] [Abstract][Full Text] [Related]
20. Targeting of FSP1 regulates iron homeostasis in drug-tolerant persister head and neck cancer cells via lipid-metabolism-driven ferroptosis.
Wu YC; Huang CS; Hsieh MS; Huang CM; Setiawan SA; Yeh CT; Kuo KT; Liu SC
Aging (Albany NY); 2024 Jan; 16(1):627-647. PubMed ID: 38206305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
